Cortistatin-17 and somatostatin-14 display the same effects on growth hormone, prolactin, and insulin secretion in patients with acromegaly or prolactinoma. 2006

S Grottoli, and V Gasco, and F Broglio, and R Baldelli, and F Ragazzoni, and F Gallenca, and A Mainolfi, and F Prodam, and G Muccioli, and E Ghigo
Division of Endocrinology and Metabolism, Department of Internal Medicine, San Giovanni Battista-Molinette Hospital, Corso Dogliotti 14, 10126 Turin, Italy.

BACKGROUND Cortistatin binds all somatostatin receptor subtypes but also has particular central actions; moreover, a specific cortistatin receptor has also been discovered. OBJECTIVE We compared the endocrine effects of cortistatin-17 with those of somatostatin-14 in patients with acromegaly (ACRO) or prolactinoma (PRLOMA). Normal subjects (NS) were studied as control group. METHODS All subjects underwent the following tests: 1) saline, 2) somatostatin-14 (2.0 microg/kg.h iv, 0-120 min) and 3) cortistatin-17 (2.0 microg/kg.h iv, 0-120 min) infusion. RESULTS Cortistatin-17 and somatostatin-14 inhibited GH secretion to the same extent in ACRO (P < 0.05) and NS (P < 0.01). Cortistatin-17 and somatostatin-14 inhibited PRL secretion in PRLOMA (P < 0.05), to some extent in ACRO (P value not significant), but not in NS. Insulin secretion was inhibited by both cortistatin-17 and somatostatin-14 to the same extent in all groups (P < 0.05). CONCLUSIONS Cortistatin-17 and somatostatin-14 display the same effects on GH, PRL, and insulin secretion in patients with ACRO or PRLOMA.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009479 Neuropeptides Peptides released by NEURONS as intercellular messengers. Many neuropeptides are also hormones released by non-neuronal cells. Neuropeptide
D010911 Pituitary Neoplasms Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA. Pituitary Cancer,Cancer of Pituitary,Cancer of the Pituitary,Pituitary Adenoma,Pituitary Carcinoma,Pituitary Tumors,Adenoma, Pituitary,Adenomas, Pituitary,Cancer, Pituitary,Cancers, Pituitary,Carcinoma, Pituitary,Carcinomas, Pituitary,Neoplasm, Pituitary,Neoplasms, Pituitary,Pituitary Adenomas,Pituitary Cancers,Pituitary Carcinomas,Pituitary Neoplasm,Pituitary Tumor,Tumor, Pituitary,Tumors, Pituitary
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D005260 Female Females
D005949 Glucose Oxidase An enzyme of the oxidoreductase class that catalyzes the conversion of beta-D-glucose and oxygen to D-glucono-1,5-lactone and peroxide. It is a flavoprotein, highly specific for beta-D-glucose. The enzyme is produced by Penicillium notatum and other fungi and has antibacterial activity in the presence of glucose and oxygen. It is used to estimate glucose concentration in blood or urine samples through the formation of colored dyes by the hydrogen peroxide produced in the reaction. (From Enzyme Nomenclature, 1992) EC 1.1.3.4. Microcid,Oxidase, Glucose

Related Publications

S Grottoli, and V Gasco, and F Broglio, and R Baldelli, and F Ragazzoni, and F Gallenca, and A Mainolfi, and F Prodam, and G Muccioli, and E Ghigo
January 1973, The Mount Sinai journal of medicine, New York,
S Grottoli, and V Gasco, and F Broglio, and R Baldelli, and F Ragazzoni, and F Gallenca, and A Mainolfi, and F Prodam, and G Muccioli, and E Ghigo
October 2004, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society,
S Grottoli, and V Gasco, and F Broglio, and R Baldelli, and F Ragazzoni, and F Gallenca, and A Mainolfi, and F Prodam, and G Muccioli, and E Ghigo
April 1974, The New England journal of medicine,
S Grottoli, and V Gasco, and F Broglio, and R Baldelli, and F Ragazzoni, and F Gallenca, and A Mainolfi, and F Prodam, and G Muccioli, and E Ghigo
March 1973, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
S Grottoli, and V Gasco, and F Broglio, and R Baldelli, and F Ragazzoni, and F Gallenca, and A Mainolfi, and F Prodam, and G Muccioli, and E Ghigo
August 1986, Clinical endocrinology,
S Grottoli, and V Gasco, and F Broglio, and R Baldelli, and F Ragazzoni, and F Gallenca, and A Mainolfi, and F Prodam, and G Muccioli, and E Ghigo
June 1979, Clinical endocrinology,
S Grottoli, and V Gasco, and F Broglio, and R Baldelli, and F Ragazzoni, and F Gallenca, and A Mainolfi, and F Prodam, and G Muccioli, and E Ghigo
January 1978, Acta endocrinologica. Supplementum,
S Grottoli, and V Gasco, and F Broglio, and R Baldelli, and F Ragazzoni, and F Gallenca, and A Mainolfi, and F Prodam, and G Muccioli, and E Ghigo
December 1986, Molecular and cellular endocrinology,
S Grottoli, and V Gasco, and F Broglio, and R Baldelli, and F Ragazzoni, and F Gallenca, and A Mainolfi, and F Prodam, and G Muccioli, and E Ghigo
September 1978, Metabolism: clinical and experimental,
S Grottoli, and V Gasco, and F Broglio, and R Baldelli, and F Ragazzoni, and F Gallenca, and A Mainolfi, and F Prodam, and G Muccioli, and E Ghigo
September 1973, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!